LeonaBio (LONA) Cash from Financing Activities (2019 - 2025)
LeonaBio (LONA) reported Cash from Financing Activities of $82.4 million for Q4 2025, up 242361.76% year-over-year from N/an in Q4 2024, and up 242361.76% quarter-over-quarter from $34000.0 in Q4 2024.
LeonaBio (LONA) Cash from Financing Activities (2019 - 2025) Analysis & Trends
LeonaBio (LONA) has 7 years of Cash from Financing Activities data on file, last reported at $82.4 million in Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at $82.4 million, up 242361.76% year-over-year; the trailing twelve-month figure through Dec 2025 was $82.5 million (up 41558.08% YoY), and the FY2025 annual result was $82.5 million, up 42405.67% from the prior year.
- Cash from Financing Activities improved to $82.4 million in Q4 2025 per LONA's latest filing, from $34000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $97.2 million in Q1 2021 and troughed at -$260000.0 in Q2 2021.
- A 5-year average of $13.9 million and a median of $147000.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2021 and 2025: Cash from Financing Activities sank 100.3% in 2021, then soared 242361.76% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at $13000.0 in 2021, then soared by 1030.77% to $147000.0 in 2022, then climbed by 3.4% to $152000.0 in 2023, then tumbled by 77.63% to $34000.0 in 2024, then soared by 242361.76% to $82.4 million in 2025.
- Business Quant data shows LONA's Cash from Financing Activities at $82.4 million in Q4 2025, $34000.0 in Q4 2024, and $12000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 7.00 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -600,000.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 53,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -538.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 85,464.43 |
| 10 | LeonaBio | 154.12 Mn | 86.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.44 Mn |
| Dec 31, 2025 | 82.44 Mn |
| Dec 31, 2024 | 34,000.00 |
| Dec 31, 2024 | 34,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Dec 31, 2023 | 152,000.00 |
| Jun 30, 2023 | 242,000.00 |
| Jun 30, 2023 | 242,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Mar 31, 2023 | 99,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Dec 31, 2022 | 147,000.00 |
| Jun 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 297,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Dec 31, 2021 | 13,000.00 |
| Dec 31, 2021 | 13,000.00 |